Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians

Immune checkpoint inhibitors (ICIs) have revolutionized the treatment and care of patients with cancer owing to unique features, including the occurrence of the so-called immune-related adverse events (irAEs). A multidisciplinary team, possibly including a cardio-oncology specialist, is warranted to...

Descripción completa

Detalles Bibliográficos
Autores principales: Raschi, Emanuel, Rossi, Simone, De Giglio, Andrea, Fusaroli, Michele, Burgazzi, Flavio, Rinaldi, Rita, Potena, Luciano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442274/
https://www.ncbi.nlm.nih.gov/pubmed/37341925
http://dx.doi.org/10.1007/s40264-023-01320-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442274/
https://www.ncbi.nlm.nih.gov/pubmed/37341925
http://dx.doi.org/10.1007/s40264-023-01320-5

Ejemplares similares